A novel series of N-(3-(6-substituted-aminopyridin-3-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides targeting TrkA receptor tyrosine kinase was identified. SAR study of the series allowed us to design and synthesize compounds possessing inhibitory activity of TrkA kinase enzyme in the low nanomolar range with low residual activity against c-Met and with no significant activity against VEGFR2.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412093 | PMC |
| http://dx.doi.org/10.1155/2012/412614 | DOI Listing |
Publication Analysis
Top Keywords
novel series
8
trka receptor
8
receptor tyrosine
8
tyrosine kinase
8
identification novel
4
series potent
4
potent trka
4
kinase inhibitors
4
inhibitors novel
4
series n-3-6-substituted-aminopyridin-3-yloxyphenyl-2-oxo-3-phenylimidazolidine-1-carboxamides
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!